NeoProfen is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Recordati Rare Diseases, Inc.. The primary component is Ibuprofen Lysine.
Product ID | 55292-122_094d15fb-6d3e-4ab9-9476-89ae9970fb9e |
NDC | 55292-122 |
Product Type | Human Prescription Drug |
Proprietary Name | NeoProfen |
Generic Name | Ibuprofen Lysine |
Dosage Form | Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2006-04-13 |
Marketing Category | NDA / NDA |
Application Number | NDA021903 |
Labeler Name | RECORDATI RARE DISEASES, INC. |
Substance Name | IBUPROFEN LYSINE |
Active Ingredient Strength | 10 mg/mL |
Pharm Classes | Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2006-04-13 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021903 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2006-04-13 |
Ingredient | Strength |
---|---|
IBUPROFEN LYSINE | 10 mg/mL |
SPL SET ID: | 6f5ede6f-b0b7-4fc8-969e-652f60ead047 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
55292-122 | NeoProfen | ibuprofen lysine |
39822-1030 | Ibuprofen Lysine | Ibuprofen Lysine |
66993-490 | Ibuprofen Lysine | ibuprofen lysine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NEOPROFEN 78435265 3213895 Live/Registered |
RECORDATI RARE DISEASES INC. 2004-06-15 |